Panagiotis Konstantinopoulos, MD
Dana-Farber Cancer Institute · Dana-Farber Cancer Institute (DFCI) · Beth Israel Deaconess Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Panagiotis Konstantinopoulos, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07832227 · Imlunestrant/Abemaciclib/Selinexor in Ovarian and EndometrialDana-Farber Cancer Institute · not yet recruiting · Low Grade Ovarian Serous Adenocarcinoma, Endometrial Cancer · principal investigator
- Ph2NCT06677190 · Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginDana-Farber Cancer Institute · recruiting · Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer · principal investigator
- Ph2NCT06518564 · Avelumab and M1774 in ARID1A-mutated Endometrial CancerPanagiotis Konstantinopoulos, MD, PhD · active not recruiting · Endometrial Cancer, ARID1A Gene Mutation, Recurrent Endometrial Carcinoma · principal investigator
- Ph2NCT06366347 · ALPINE: Maintenance Letrozole/AbemaciclibDana-Farber Cancer Institute · recruiting · Endometrial Cancer, Recurrent Endometrial Cancer, TP53 · principal investigator
- Ph2NCT05548296 · A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaAcrivon Therapeutics · recruiting · Endometrial Adenocarcinoma · principal investigator
- Ph1NCT04024878 · NeoVax With Nivolumab in Patients With Ovarian CancerDana-Farber Cancer Institute · active not recruiting · Ovarian Cancer · principal investigator
- Ph2NCT02912572 · Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial CancerDana-Farber Cancer Institute · active not recruiting · Metastatic Endometrial Cancer · principal investigator
- Ph2NCT00866723 · Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube CancerBeth Israel Deaconess Medical Center · terminated · Ovarian Cancer, Primary Peritoneal Serous Cancer, Fallopian Tube Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancerP50CA240243 · NCI · DANA-FARBER CANCER INST · PI Panagiotis Konstantinopoulos · fiscal years 2020 to 2024Named on NCT04024878
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.